Black Bird Biotech (BBBT) Stock Statistics & Valuation Metrics
Total Valuation
Black Bird Biotech has a market cap or net worth of $3,729.00. The enterprise value is $723.73B.
- Market Cap
- $3,729.00
- Enterprise Value
- $723.73B
Share Statistics
Black Bird Biotech has 3,728,974,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,728,974,900
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Black Bird Biotech’s return on equity (ROE) is 2.55 and return on invested capital (ROIC) is -6571.45%.
- Return on Equity (ROE)
- 2.55
- Return on Assets (ROA)
- -7.59
- Return on Invested Capital (ROIC)
- -6571.45%
- Return on Capital Employed (ROCE)
- 1.98
- Revenue Per Employee
- 20.64K
- Profits Per Employee
- -414.69K
- Employee Count
- 4
- Asset Turnover
- 0.38
- Inventory Turnover
- 1.57
Valuation Ratios
The current PE Ratio of Black Bird Biotech is -0.02. Black Bird Biotech’s PEG ratio is -0.00.
- PE Ratio
- -0.02
- PS Ratio
- 1.19
- PB Ratio
- -0.05
- Price to FCF
- -0.10
- Price to Operating Cash Flow
- -0.03
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Black Bird Biotech had revenue of 82.56K and earned -1.66M in profits. Earnings per share was -0.01.
- Revenue
- 82.56K
- Gross Profit
- -55.91K
- Operating Income
- -1.29M
- Pretax Income
- -1.66M
- Net Income
- -1.66M
- EBITDA
- -1.20M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -233.06K and capital expenditures 0, giving a free cash flow of -233.06K billion.
- Operating Cash Flow
- -233.06K
- Free Cash Flow
- -233.06K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Black Bird Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1049.31%
- Earnings Yield
- -5015.49%
Stock Price Statistics
- Beta
- 109.11
- 52-Week Price Change
- -70.59%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Black Bird Biotech as a current ratio of 0.16, with Debt / Equity ratio of -103.02%
- Current Ratio
- 0.16
- Quick Ratio
- 0.05
- Debt to Market Cap
- 2.70
- Net Debt to EBITDA
- -0.52
- Interest Coverage Ratio
- -3.48
Taxes
In the past 12 months, Black Bird Biotech has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Black Bird Biotech EV to EBITDA ratio is -0.60, with an EV/FCF ratio of -0.70.
- EV to Sales
- 8.77
- EV to EBITDA
- -0.60
- EV to Free Cash Flow
- -0.70
- EV to Operating Cash Flow
- -0.70
Balance Sheet
Black Bird Biotech has $5,729.00 in cash and marketable securities with $748.11K in debt, giving a net cash position of -$742.38K billion.
- Cash & Marketable Securities
- $5,729.00
- Total Debt
- $748.11K
- Net Cash
- -$742.38K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is -67.71%, with operating margin of -1560.42%, and net profit margin of -2009.09%.
- Gross Margin
- -67.71%
- Operating Margin
- -1560.42%
- Pretax Margin
- -2009.09%
- Net Profit Margin
- -2009.09%
- EBITDA Margin
- -1452.55%
- EBIT Margin
- -1560.24%
Analyst Forecast
The average price target for Black Bird Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
